computational biology
Nucleome Therapeutics Collaborating With J&J to Identify Target Genes in Autoimmune Diseases
The companies will study genetic associations linked to autoimmune diseases to identify target genes as well as patients most likely to respond to therapy.
The firm is looking for funding and partnerships to continue demonstrating the capabilities of its mechanistic approach that simulates treatment responses in in silico tumor models.
Transcriptomic Classification of Pediatric Cancers Shows Potential to Improve Clinical Diagnoses
Premium
In a new paper, computational biologists at Toronto's Hospital for Sick Children described their atlas of childhood cancer subtypes and a corresponding search tool.
Tavros Therapeutics, Bayer Subsidiary Vividion Ink Precision Oncology Deal
The firms are teaming up to identify new tumor vulnerabilities that can potentially serve as targets for new or existing therapeutic molecules.
Engine Biosciences Closes $43M Series A Round
The AI-powered bioinformatics startup will use the money to launch clinical drug discovery programs in precision oncology.